Sign in

CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823929248
Phone
858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Director bought 40,000 shares at $15.45 ($618,000)
  4. 8-K Event Executive or director change
  5. 3 Insider Initial Statement of Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Executive or director change
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SC 13G Stake Amended Statement of Ownership
  17. SC 13D Stake Beneficial Ownership Report
  18. 4 Open-market buy Chief Operating Officer bought 3,050 shares at $20.00 ($61,000)
  19. 4 Conversion 10% owner acquired 4,720,830 shares (conversion)
  20. 4 Open-market buy 10% owner bought 250,000 shares at $20.00 ($5,000,000)

Page 11 of 14 · 268 filings